openPR Logo

Press Releases from Telangiectasis Therapeutics-Pharma Proff (1 total)

Telangiectasias Therapeutics- Pipeline Analysis 2018, Clinical Trials & Results

Telangiectasias are dilated blood vessels located near the surface of skin or mucous membranes. These often appear as fine pink or red lines, which temporarily whiten under pressure. Although this disease can be developed in healthy individuals, telangiectasias is known to be a prime feature of systemic and limited scleroderma and dermatomyositis. Download the sample report at: https://www.pharmaproff.com/request-sample/1008 Telangiectasias may occur in rosacea, in certain systemic diseases (such as ataxia-telangiectasia, scleroderma),

Go To Page:   1 2 3 4 5 6 7 8 9 10